For many of our patients, the results speak for themselves, and the improvements in look, feel, and function far outweigh the fact that current insurance companies refuse to recognize these improvements
Neuroprotective Properties Under Investigation The Zagreb groups 2016 review in Current Neuropharmacology described peripheral BPC-157 administration altering serotonin synthesis rates in specific brain regions, particularly nigrostriatal and other dopaminergic pathways (Tohyama, Sikiric, Diksic, 2004, Life Sciences )
The study further elucidated the signaling pathway involved, showing that BPC 157 enhanced the phosphorylation of Src, Caveolin-1 (Cav-1), and endothelial nitric oxide synthase (eNOS)
As a best practice for any research supplier, prioritize recent third-party testing, a verified COA, and results from an ISO/IEC 17025accredited laboratory to support identity confirmation and batch-to-batch consistency
With more research and better understanding, the peptide rules might change to be safe, helpful, and accessible to those who can benefit from them
